In one paragraphArticle in Proceedings of the National Academy of Sciences of the United States of America, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
2 · The registryThe trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
3 · Its place in the literatureWho cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
4 · The recordCorrections and comments
5 · Who and what moneyAuthors and funding
9 authors.
Rafael Rivera-LugoDepartment of Molecular and Cell Biology, University of California Berkeley, Berkeley, CA 94720.ORCID 0000-0002-2346-2297 Jesse Garcia CastilloDepartment of Molecular and Cell Biology, University of California Berkeley, Berkeley, CA 94720.
Mariya LobanovskaDepartment of Molecular and Cell Biology, University of California Berkeley, Berkeley, CA 94720.ORCID 0000-0002-3513-301X Eugene TangDepartment of Molecular and Cell Biology, University of California Berkeley, Berkeley, CA 94720.
Andrea Anaya-SanchezGraduate Group in Microbiology, University of California Berkeley, Berkeley, CA 94720.
Scott EspichDivision of Infectious Disease and Vaccinology, School of Public Health, University of California Berkeley, Berkeley, CA 94720.
Sarah A StanleyDepartment of Molecular and Cell Biology, University of California Berkeley, Berkeley, CA 94720.ORCID 0000-0002-4182-9048 Michel DuPageDepartment of Molecular and Cell Biology, University of California Berkeley, Berkeley, CA 94720.ORCID 0000-0002-1479-9840 Daniel A PortnoyDepartment of Molecular and Cell Biology, University of California Berkeley, Berkeley, CA 94720.ORCID 0000-0003-1218-2799 Funding
Cal | Henry Wheeler Center for Emerging and Neglected Diseases (CEND) CEND fellowshipCancer Research Coordinating Committee (CRCC) C23CR5612HHMI (HHMI) HHMI Gilliam FellowshipHHS | NIH | National Cancer Institute (NCI) 1DP2CA247830-01HHS | NIH | National Cancer Institute (NCI) 5R01 CA283604HHS | NIH | National Institute of Allergy and Infectious Diseases (NIAID) 1P01 AI063302HHS | NIH | National Institute of Allergy and Infectious Diseases (NIAID) 1R01 AI027655HHS | NIH | National Institute of Allergy and Infectious Diseases (NIAID) R01AI113270-01A1HHS | NIH | National Institute of Allergy and Infectious Diseases (NIAID) R01AI153197-01NRC | Ford Foundation Fellowships (Ford Foundation Fellowship Programs) Ford Foundation FellowshipUCSF-UCB SAR Program UCSF-UCB SAR ProgramUniversity of California (UC) University of California Dissertation-Year Fellowship
6 · The paper itselfAbstract
Mucosal-associated invariant T (MAIT) cells are among the most conserved and abundant innate-like T cells in humans that recognize microbial-derived riboflavin precursors and elicit potent antimicrobial responses. The foodborne pathogen
Indexed as
Listeria monocytogenesListeriosisMucosal-Associated Invariant T CellsAnimalsFemaleHumansMiceMice, Inbred C57BLPerforinRiboflavinPerforinRiboflavincancerFrancisellamacrophageperforinriboflavin
Identifiers
PMID42258727
PMCPMC13273239
What OpenQuestion holds
Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390